Abc NDC 60986-2035

NDC codes

FDA NDC Directory

Product NDC (as listed)60986-2035Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60986-2035Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60986-2035-3	60986203503	50 mL in 1 BOTTLE, DROPPER (60986-2035-3)Marketed from Dec 3, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Abc
Generic name (nonproprietary): aconitum napellus, belladonna, chamomilla
Active ingredients: Aconitum napellus — 3 [hp_X]/100mLMatricaria recutita — 3 [hp_X]/100mLBelladonna leaf — 3 [hp_X]/100mL
Dosage form: Liquid
Route: Oral
Labeler: MARCO PHARMA INTERNATIONAL LLC
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jan 22, 2015
Listing expires: Dec 31, 2027
Identifiers: Product ID 60986-2035_483b7f10-381e-7b69-e063-6394a90a621fSPL ID 483b7f10-381e-7b69-e063-6394a90a621fSPL set ID 44749e04-ca70-410d-a754-8befe8da11e7UNII U0NQ8555JD, G0R4UBI2ZZ, 6GZW20TIOI

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460986203503 followed by a unit qualifier and the quantity

Package 60986-2035-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 12, 2026.

Indications (excerpt from the label)

FOR TEMPORARY RELIEF OF EARACHE

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)